These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10519899)

  • 21. Growth hormone therapy in adults and children.
    Levy RM
    N Engl J Med; 2000 Feb; 342(5):359. PubMed ID: 10660404
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth hormone therapy in children in Canada: what have we learned in the past decade from an unlimited supply of growth hormone?
    Dean H
    Clin Invest Med; 1999 Apr; 22(2):60-2. PubMed ID: 10340105
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of GH as pharmacological agent (minireview).
    Wit JM
    Endocr Regul; 2000 Mar; 34(1):28-32. PubMed ID: 10808250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and potential therapeutic uses of growth hormone and insulin-like growth factor I.
    Hintz RL
    Endocrinol Metab Clin North Am; 1996 Sep; 25(3):759-73. PubMed ID: 8879998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of recombinant Human Growth Hormone (rHGH)].
    Calzada-León R
    Rev Med Inst Mex Seguro Soc; 2017; 55(2):196-213. PubMed ID: 28296370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone deficiency in children with myelomeningocele (MMC)--effects of growth hormone treatment.
    Trollmann R; Strehl E; Dörr HG
    Eur J Pediatr Surg; 1997 Dec; 7 Suppl 1():58-9. PubMed ID: 9497133
    [No Abstract]   [Full Text] [Related]  

  • 27. Four decades of growth hormone therapy for short children: what have we achieved?
    Guyda HJ
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4307-16. PubMed ID: 10599680
    [No Abstract]   [Full Text] [Related]  

  • 28. Short stature and growth hormone.
    Kamboj M
    Indian J Pediatr; 2005 Feb; 72(2):149-57. PubMed ID: 15758539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone therapy.
    Bhatia V
    Indian Pediatr; 1997 Aug; 34(8):675-9. PubMed ID: 9492395
    [No Abstract]   [Full Text] [Related]  

  • 30. Benign intracranial hypertension (pseudotumour cerebri) during rhGH therapy.
    Querfeld U
    Br J Clin Pract Suppl; 1996 Aug; 85():68. PubMed ID: 8995039
    [No Abstract]   [Full Text] [Related]  

  • 31. [Other indications for growth hormone treatment: chronic kidney failure and Turner's syndrome].
    Martul P; Rodríguez Soriano J; Vallo A; Oliveros R; Igea J; Loridan L; Pineda J
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():178-81. PubMed ID: 1636962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of growth hormone treatment on pubertal growth in a boy with cystinosis and growth failure after renal transplantation.
    Haffner D; Wühl E; Nissel R; Schaefer F; Mehls O
    Br J Clin Pract Suppl; 1996 Aug; 85():7-9. PubMed ID: 8995018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.
    Khatchadourian K; Huot C; Alos N; Van Vliet G; Deal C
    Horm Res; 2008; 70(5):300-8. PubMed ID: 18824869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of treatment with recombinant human growth hormone in children with growth retardation in end-stage renal disease].
    Sieniawska M; Pańczyk-Tomaszewska M; Ziółkowska H; Jedrzejowski A; Leszczyńska B; Dyras P; Kałuzyńska A; Makulska I; Pietrzyk JA; Rubik J; Siteń G; Stachowski J; Szprynger K; Zurowska A; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2001 Apr; 10(58):263-6. PubMed ID: 11434172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the response to rhGH in peritoneal dialysis patients less effective than in patients with chronic renal insufficiency.
    Perfumo F; Verrina E; Edefonti A; Trivelli A; Canepa A; Gusmano R
    Br J Clin Pract Suppl; 1996 Aug; 85():18-20. PubMed ID: 8995022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic consequences of growth hormone treatment in paediatric practice.
    Saenger P
    Horm Res; 2000; 53 Suppl 1():60-9. PubMed ID: 10895045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.
    Bryant J; Cave C; Mihaylova B; Chase D; McIntyre L; Gerard K; Milne R
    Health Technol Assess; 2002; 6(18):1-168. PubMed ID: 12433316
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of diabetes among children treated with growth hormone in Israel.
    Lutski M; Zucker I; Zadik Z; Libruder C; Blumenfeld O; Shohat T; Laron Z
    Diabet Med; 2019 Oct; 36(10):1276-1281. PubMed ID: 30690790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study.
    Noto R; Maneatis T; Frane J; Alexander K; Lippe B; Davis DA
    J Pediatr Endocrinol Metab; 2011; 24(9-10):627-31. PubMed ID: 22145447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.